Assunto: DOENÇAS CARDIOVASCULARES
ABNT
MARIN NETO, J A. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet, v. 367, n. 9526, p. 1903-1912, 2006Tradução . . Acesso em: 12 maio 2025.APA
Marin Neto, J. A. (2006). Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet, 367( 9526), 1903-1912.NLM
Marin Neto JA. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006 ; 367( 9526): 1903-1912.[citado 2025 maio 12 ]Vancouver
Marin Neto JA. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006 ; 367( 9526): 1903-1912.[citado 2025 maio 12 ]